Depomed reported $10.54M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aerie Pharmaceuticals AERI:US $ 28.15M 3.38M
Ani Pharmaceuticals ANIP:US $ 31.96M 3.14M
Aurora Cannabis Inc ACB:CN 43.17M 3.69M
Cara Therapeutics CARA:US $ 7.54M 1.78M
Daiichi Sankyo 4568:JP 96.37B 8.36B
Depomed DEPO:US $ 10.54M 105K
Ironwood Pharmaceuticals IRWD:US $ 30.12M 1.26M
Johnson & Johnson JNJ:US $ 6.23B 288M
Knight Therapeutics Inc GUD:CN C$ 21.49M 2.97M
Merk MRK:US $ 2.42B 118M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Omeros OMER:US $ 13.92M 2.96M
Pfizer PFE:US $ 3.2B 506M
Teva Pharmaceutical TEVA:IT 849M 30M